CEL Total Assets from 2010 to 2026
| CVM Stock | USD 4.83 0.07 1.43% |
Total Assets | First Reported 1986-09-30 | Previous Quarter 20.3 M | Current Value 28.2 B | Quarterly Volatility 2.3 B |
Check CEL SCI financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CEL SCI's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.7 M, Interest Expense of 783.6 K or Selling General Administrative of 5.5 M, as well as many indicators such as Price To Sales Ratio of 861, Dividend Yield of 0.0762 or PTB Ratio of 2.0. CEL financial statements analysis is a perfect complement when working with CEL SCI Valuation or Volatility modules.
CEL | Total Assets | Build AI portfolio with CEL Stock |
Evaluating CEL SCI's Total Assets across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into CEL SCI Corp's fundamental strength.
Latest CEL SCI's Total Assets Growth Pattern
Below is the plot of the Total Assets of CEL SCI Corp over the last few years. Total assets refers to the total amount of CEL SCI assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in CEL SCI Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. CEL SCI's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CEL SCI's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 28.16 B | 10 Years Trend |
|
Total Assets |
| Timeline |
CEL Total Assets Regression Statistics
| Arithmetic Mean | 5,582,999,409 | |
| Geometric Mean | 67,760,204 | |
| Coefficient Of Variation | 222.42 | |
| Mean Deviation | 9,151,050,080 | |
| Median | 27,622,994 | |
| Standard Deviation | 12,417,599,127 | |
| Sample Variance | 154196768.1T | |
| Range | 34B | |
| R-Value | 0.67 | |
| Mean Square Error | 91624017.4T | |
| R-Squared | 0.44 | |
| Significance | 0 | |
| Slope | 1,636,582,423 | |
| Total Sum of Squares | 2467148289.3T |
CEL Total Assets History
Other Fundumenentals of CEL SCI Corp
CEL SCI Total Assets component correlations
Click cells to compare fundamentals
About CEL SCI Financial Statements
CEL SCI investors utilize fundamental indicators, such as Total Assets, to predict how CEL Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Assets | 32.4 B | 34 B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of CEL SCI Correlation against competitors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Will Biotechnology sector continue expanding? Could CEL diversify its offerings? Factors like these will boost the valuation of CEL SCI. Projected growth potential of CEL fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CEL SCI data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (6.27) | Revenue Per Share | Quarterly Revenue Growth (0.63) | Return On Assets | Return On Equity |
Understanding CEL SCI Corp requires distinguishing between market price and book value, where the latter reflects CEL's accounting equity. The concept of intrinsic value - what CEL SCI's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push CEL SCI's price substantially above or below its fundamental value.
It's important to distinguish between CEL SCI's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CEL SCI should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, CEL SCI's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.